Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-5885 +/- GS-9451 with PEG/RBV in HCV Genotype 1
NCT01356160Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of vedroprevir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Jul 2011; status: completed.
02
Drugs
vedroprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01356160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01356160.